The polypeptide antifungal agent (X-5079C): further studies in 39 patients.

MLA

Witorsch, P., et al. “The Polypeptide Antifungal Agent (X-5079C): Further Studies in 39 Patients.” The American Review of Respiratory Disease, vol. 93, no. 6, June 1966, pp. 876–88. EBSCOhost, https://doi.org/10.1164/arrd.1966.93.6.876.

APA

Witorsch, P., Andriole, V. T., Emmons, C. W., & Utz, J. P. (1966). The polypeptide antifungal agent (X-5079C): further studies in 39 patients. The American Review of Respiratory Disease, 93(6), 876–888. https://doi.org/10.1164/arrd.1966.93.6.876

Chicago

Witorsch, P, V T Andriole, C W Emmons, and J P Utz. 1966. “The Polypeptide Antifungal Agent (X-5079C): Further Studies in 39 Patients.” The American Review of Respiratory Disease 93 (6): 876–88. doi:10.1164/arrd.1966.93.6.876.